Inhibikase Therapeutics Inc (IKT)
Who owns Inhibikase Therapeutics Inc (IKT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 65.8% of the shares are freely tradable; institutional investors hold 93.4%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Sands Capital Ventures, LLC | 9.86 | 13,018,965 | +0.0 | 03/31/2026 |
| Soleus Capital Management, L.P. | 8.24 | 10,875,000 | +0.0 | 03/31/2026 |
| Fairmount Funds Management LLC | 6.53 | 8,625,000 | +0.0 | 03/31/2026 |
| Trails Edge Capital Partners, LP | 6.10 | 8,057,345 | +30.4 | 03/31/2026 |
| ADAR1 Capital Management LLC | 5.00 | 6,606,572 | -18.1 | 03/31/2026 |
| Kalehua Capital Management LLC | 4.92 | 6,494,498 | +271.1 | 03/31/2026 |
| BlackRock Inc | 4.77 | 6,303,433 | +90.7 | 03/31/2026 |
| Blackstone Inc | 4.50 | 5,938,276 | +0.0 | 03/31/2026 |
| Siren, L.L.C. | 4.43 | 5,850,000 | +0.0 | 03/31/2026 |
| COMMODORE CAPITAL LP | 4.09 | 5,397,488 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 30. Jul 2026 | Berman Dennis N | Director | Other | 21,854 | 1.26 | 27,536 |
| 29. Jul 2026 | Ra Capital Management, L.p. | 10% Owner | Other | 18,030,000 | – | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.